Type 1 conventional dendritic cells: ontogeny, function, and emerging roles in cancer immunotherapy
- Details
- Publication Year 2021-12,Volume 42,Issue #12,Page 1113-1127
- Journal Title
- Trends in Immunology
- Abstract
- Dendritic cells (DCs) are key immune sentinels that orchestrate protective immune responses against pathogens or cancers. DCs have evolved into multiple phenotypically, anatomically, and functionally distinct cell types. One of these DC types, Type 1 conventional DCs (cDC1s), are uniquely equipped to promote cytotoxic CD8(+) T cell differentiation and, therefore, represent a promising target for harnessing antitumor immunity. Indeed, recent studies have highlighted the importance of cDC1s in tumor immunotherapy using immune checkpoint inhibitors. Here, we review the progress in defining the key developmental and functional attributes of cDC1s and the approaches to optimizing the potency of cDC1s for anticancer immunity.
- Publisher
- Elsevier
- Keywords
- antigen presentation; cytokines; myelopoiesis; transcription; tumor immunity; interests
- Research Division(s)
- Immunology
- PubMed ID
- 34728143
- Publisher's Version
- https://doi.org/10.1016/j.it.2021.10.004
- Terms of Use/Rights Notice
- Refer to copyright notice on published article.
Creation Date: 2022-02-08 02:27:52
Last Modified: 2022-02-08 02:30:46